Intel (INTC) stock climbed 2.57% to $47.98 on March 11 amid Panther Lake chip news and Core Ultra processor launch announcements. Analysis and outlook. The postIntel (INTC) stock climbed 2.57% to $47.98 on March 11 amid Panther Lake chip news and Core Ultra processor launch announcements. Analysis and outlook. The post

Intel (INTC) Stock Climbs 2.57% Following Panther Lake Announcement and Processor Launches

2026/03/12 19:05
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Takeaways

  • Shares of Intel (INTC) climbed 2.57% to reach $47.98 on March 11, extending a three-session winning streak.
  • The rally followed announcements regarding Panther Lake chip deployment and confirmation that Core Ultra 7 270K Plus and Core Ultra 5 250K Plus will ship on March 26.
  • Industry sources indicate Intel is approaching “full capacity” as AI infrastructure requirements drive server processor demand.
  • Wall Street maintains a “Reduce” consensus rating with a $45.74 average price target, though certain analysts have upgraded their outlook.
  • Intel delivered stronger performance than NVIDIA, Broadcom, and Qualcomm during a session where broader indices declined.

Intel (INTC) finished Wednesday’s session at $47.98, posting a 2.57% advance while major benchmarks struggled. The S&P 500 dipped 0.08% and the Dow Jones Industrial Average declined 0.61%, highlighting Intel’s relative strength.


INTC Stock Card
Intel Corporation, INTC

The chipmaker extended its winning streak to three trading days. Volume registered at 71.6 million shares, noticeably lighter than the 50-day average of 108.2 million, indicating the advance occurred without heavy participation from new market entrants.

Shares peaked at $48.83 during intraday trading before settling at the $47.98 close. The stock’s 52-week peak of $54.60 was established on January 22.

The upward movement partially stemmed from developments surrounding Intel’s Panther Lake processor roadmap. Chief Executive Lip-Bu Tan disclosed that external foundry clients are actively participating as the company advances its manufacturing-as-a-service initiative.

The company also verified shipping dates for its Core Ultra 7 270K Plus and Core Ultra 5 250K Plus processors, scheduled for March 26 availability. Suggested pricing is positioned at $299 and $199 respectively.

Earlier this week, the Arrow Lake Refresh unveiling and Core Series 2/Core Ultra product family introduction had already sparked investor enthusiasm. Market reactions included double-digit intraday price movements, demonstrating heightened attention to Intel’s processor portfolio.

Artificial Intelligence Infrastructure and Manufacturing Capacity

Industry reports indicate Intel is operating at approximately “full capacity” as artificial intelligence infrastructure customers increase server chip procurement. Limited supply availability in this segment can strengthen pricing dynamics for manufacturers capable of meeting delivery commitments.

Acer recently unveiled new TravelMate Copilot+ notebook computers powered by Intel Core Ultra Series 3 processors, demonstrating original equipment manufacturer adoption of Intel’s newest mobile AI silicon. Additionally, Intel and Infosys broadened a strategic artificial intelligence infrastructure collaboration, potentially channeling additional enterprise computing workloads to Intel-based systems.

Intel disclosed fourth quarter results on January 22, delivering earnings per share of $0.15, surpassing the $0.08 consensus forecast. Revenue totaled $13.67 billion, exceeding the $13.37 billion analyst projection, despite representing a 4.2% year-over-year decline.

The company’s first quarter 2026 EPS guidance stands at $0.00, while Wall Street analysts project an average of -$0.11 EPS for the complete fiscal year.

Wall Street Perspective

Analyst opinion remains divided. Tigress Financial maintains a “buy” recommendation with a $66 price objective. UBS projects a $51 target. Northland Securities established a $54 forecast. Conversely, Rosenblatt carries a “sell” rating with a $30 target, while Citi has highlighted macroeconomic and competitive headwinds.

In aggregate, 5 analysts recommend buying INTC, 26 suggest holding, and 6 advise selling. The overall consensus stands at “Reduce” with a mean price target of $45.74 — trailing Wednesday’s closing level.

Intel ranks among the most heavily shorted Dow components, introducing additional volatility dynamics to the current uptrend.

Regarding insider activity, Executive Vice President David Zinsner acquired 5,882 shares at $42.50 in late January. Executive Vice President April Miller divested 20,000 shares at $49.05 in early February.

Intel’s 50-day moving average stands at $45.84. The 200-day moving average is positioned at $38.55. Institutional ownership represents 64.53% of outstanding shares.

The post Intel (INTC) Stock Climbs 2.57% Following Panther Lake Announcement and Processor Launches appeared first on Blockonomi.

Market Opportunity
Panther Protocol Logo
Panther Protocol Price(PANTHER)
$0.008109
$0.008109$0.008109
+1.26%
USD
Panther Protocol (PANTHER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Uniswap Price Compression Signals Potential Breakout Toward $5.30

Uniswap Price Compression Signals Potential Breakout Toward $5.30

TLDR: The Uniswap (UNI) price is consolidating within an ascending triangle between $3.80 and $4.10. A clean breakout above $4.10 could trigger a 30% rally toward
Share
Blockonomi2026/03/16 06:37
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29
Unleashing A New Era Of Seller Empowerment

Unleashing A New Era Of Seller Empowerment

The post Unleashing A New Era Of Seller Empowerment appeared on BitcoinEthereumNews.com. Amazon AI Agent: Unleashing A New Era Of Seller Empowerment Skip to content Home AI News Amazon AI Agent: Unleashing a New Era of Seller Empowerment Source: https://bitcoinworld.co.in/amazon-ai-seller-tools/
Share
BitcoinEthereumNews2025/09/18 00:10